SG47083A1 - Antiflammatory and analgesis gel preparation - Google Patents

Antiflammatory and analgesis gel preparation

Info

Publication number
SG47083A1
SG47083A1 SG1996005835A SG1996005835A SG47083A1 SG 47083 A1 SG47083 A1 SG 47083A1 SG 1996005835 A SG1996005835 A SG 1996005835A SG 1996005835 A SG1996005835 A SG 1996005835A SG 47083 A1 SG47083 A1 SG 47083A1
Authority
SG
Singapore
Prior art keywords
antiflammatory
analgesis
gel preparation
gel
preparation
Prior art date
Application number
SG1996005835A
Other languages
English (en)
Inventor
Yasuo Ikeda
Shuichi Kasai
Saturu Enomoto
Katsumi Imamori
Akira Iwasa
Original Assignee
Ss Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ss Pharmaceutical Co filed Critical Ss Pharmaceutical Co
Publication of SG47083A1 publication Critical patent/SG47083A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG1996005835A 1992-12-04 1993-11-26 Antiflammatory and analgesis gel preparation SG47083A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4325632A JP2523428B2 (ja) 1992-12-04 1992-12-04 消炎鎮痛ゲル製剤

Publications (1)

Publication Number Publication Date
SG47083A1 true SG47083A1 (en) 1998-03-20

Family

ID=18179022

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005835A SG47083A1 (en) 1992-12-04 1993-11-26 Antiflammatory and analgesis gel preparation

Country Status (10)

Country Link
US (1) US5422102A (de)
EP (1) EP0600395B1 (de)
JP (1) JP2523428B2 (de)
KR (1) KR100245994B1 (de)
CA (1) CA2110119C (de)
DE (1) DE69328067T2 (de)
ES (1) ES2145023T3 (de)
HK (1) HK1012570A1 (de)
SG (1) SG47083A1 (de)
WO (1) WO1994013281A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
CN1161117C (zh) * 1998-04-27 2004-08-11 藤泽药品工业株式会社 药物组合物
EP1082290B1 (de) * 1998-04-28 2003-11-26 Russinsky Limited Verfahren zur herstellung von aceclofenac
KR100348100B1 (ko) * 1998-07-31 2002-11-07 하나제약 주식회사 2-[(2,6-디클로로페닐)아미노]페닐아세톡시아세트산의제조방법
US20030198616A1 (en) * 2002-04-23 2003-10-23 Combe Incorporated Moisturizing skin gel and method
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
US20050137164A1 (en) * 2003-09-22 2005-06-23 Moshe Arkin Diclofenac compositions for the treatment of skin disorders
JP4820065B2 (ja) * 2004-05-24 2011-11-24 同仁医薬化工株式会社 消炎鎮痛外用水性液剤
NZ577020A (en) 2006-10-17 2012-05-25 Nuvo Res Inc Diclofenac gel containing dimethyl sulfoxide (dmso)
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8697043B1 (en) * 2013-01-08 2014-04-15 Chattem, Inc. Odor suppression of volatile organic analgesic compounds and method of use
WO2016121996A1 (ja) 2015-01-30 2016-08-04 株式会社メドレックス 水性外用剤
EP4262780A4 (de) * 2020-12-16 2024-11-13 New Frontier Labs, LLC Dicarbonsäureester zur behandlung von erkrankungen und leiden im zusammenhang mit phospholipase-d-toxin
CN116829141A (zh) * 2020-12-16 2023-09-29 新前沿实验室有限责任公司 用于诱导镇痛作用的二羧酸酯
CN112516081B (zh) * 2020-12-16 2023-03-10 郑州百瑞动物药业有限公司 一种双氯芬酸注射液及其制备方法
WO2022249748A1 (ja) * 2021-05-24 2022-12-01 住友精化株式会社 ゲル状組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
JPS63222121A (ja) * 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性ゲル製剤
JPH0696527B2 (ja) * 1987-05-20 1994-11-30 佐藤製薬株式会社 消炎鎮痛ゲル剤
ES2078256T3 (es) * 1990-04-05 1995-12-16 Knoll Ag Formula farmaceutica para uso topico que contiene diclofenaco sodico.
CA2058975C (en) * 1990-10-30 2000-06-06 Shuichi Kasai Antiinflammatory gel preparation
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤

Also Published As

Publication number Publication date
DE69328067T2 (de) 2000-09-14
JPH07173058A (ja) 1995-07-11
JP2523428B2 (ja) 1996-08-07
EP0600395B1 (de) 2000-03-15
CA2110119C (en) 2003-05-27
US5422102A (en) 1995-06-06
KR940013497A (ko) 1994-07-15
ES2145023T3 (es) 2000-07-01
EP0600395A1 (de) 1994-06-08
HK1012570A1 (en) 1999-08-06
CA2110119A1 (en) 1994-06-05
DE69328067D1 (de) 2000-04-20
KR100245994B1 (ko) 2000-04-01
WO1994013281A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
GB9218749D0 (en) Alginate gels
AU5010793A (en) Human interleukin-13
EP0459733A3 (en) Alginate gels
AR244916A1 (es) Una cubierta para un sustrato alargado y un conjunto de partes para formarla.
GB9204769D0 (en) Workcentre and supports
ZA936097B (en) Human interleukin-13
GB9403043D0 (en) Gel
SG47083A1 (en) Antiflammatory and analgesis gel preparation
GB2217595B (en) Antiinflammatory gel
EP0570252A3 (en) Low gel strength agar-agar
GB9204770D0 (en) Workcentre and supports
HU9303442D0 (en) Jodinated benzoyl-acetats and ketals
GB9214584D0 (en) Cosmetic gel
AU5737494A (en) Human thrombospondin-4
ZA93582B (en) Substituted hexahyhdroazephinones and tetrahydrobenzazepinones
GB9402992D0 (en) Gel
AU3404293A (en) Novel substituted stannosilicates and preparation thereof
KR960009235B1 (en) Compress
GB2275266A8 (en) Preparation of 2-methyl-3-aminobenzotrifluoride
AU649697B2 (en) Improvements and modifications to insulated containers
EP0596361A3 (en) Chloro-(2-halo-1-fluoromethyl-ethoxy) methanes and their preparation
GB9213879D0 (en) Gel material
GB9224070D0 (en) Catalyst and preparation
IL100803A0 (en) Skin gel
GB9324725D0 (en) Ficyclic compounds and preparation thereof